News

Spinal spasticity is a common symptom of neurological conditions such as spinal cord injury or multiple sclerosis. It affects not only mobility but also daily comfort, making basic activities and self-care more difficult. In many cases, medication becomes the primary method of managing these symptoms.

Sleeping pills can affect bladder control, especially at night. By changing how the body responds during sleep, they may make it harder to wake in time or react to physical signals, even when bladder function itself remains normal. In this article, we look at how sleeping pills and related medications influence nighttime incontinence and why these changes tend to become more noticeable after starting or adjusting medication.

Urinary tract infections (UTIs) in men are less common than in women, but when they occur, they often require careful evaluation. Unlike uncomplicated bladder infections, UTIs in men are frequently associated with underlying conditions, which makes early assessment especially important.

Many men seek medical advice for urinary symptoms, expecting clarity, but instead leave feeling uncertain or dismissed. Subtle changes such as urgency, discomfort, or recurring infections are sometimes brushed off as stress, ageing, or lifestyle-related, even when they persist or worsen.

Spasticity after spinal cord injury is common, yet often difficult to understand. For many people, it appears unexpectedly as sudden muscle tightness, involuntary movements, or persistent stiffness that interferes with everyday activities. These changes can be confusing, especially when they occur in parts of the body with little or no voluntary movement.

During palliative care, changes in a patient’s urination and urinary incontinence may be caused by the underlying disease or a consequence of comorbid conditions. In some cases, symptoms worsen gradually, while in others they may occur quite suddenly, creating additional stress for the patient and family.

Multiple System Atrophy (MSA) is a condition in which the functioning of brain structures changes. Autonomic control centres affected by MSA are responsible for coordinating and regulating automatic processes. Symptoms can manifest themselves in different ways and gradually change a person's daily functioning, which is why ongoing monitoring within the UK healthcare system is often required.

While most people are familiar with types 1 and 2 of this disease, not everyone has heard of type 3. Scientists introduced this term relatively recently and often use it when talking about brain function, memory, and various cognitive processes. Type 3 diabetes can develop quite imperceptibly, with the person experiencing numerous changes, from impaired thinking and concentration to low mood and energy levels. Physical symptoms such as urinary incontinence or bladder control problems may also develop over time.